Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.
“Patients whose prostate tumors lose reliance on the androgen receptor do poorly. Our results suggest a therapeutic approach for…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply